Group One Trading’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,124
| Closed | -$2.62K | – | 2414 |
|
|
2025
Q1 | $2.62K | Sell |
4,124
-100
| -2% | -$64 | ﹤0.01% | 1645 |
|
|
2024
Q4 | $4.35K | Sell |
4,224
-687
| -14% | -$708 | ﹤0.01% | 1659 |
|
|
2024
Q3 | $5.8K | Sell |
4,911
-12,053
| -71% | -$14.2K | ﹤0.01% | 1347 |
|
|
2024
Q2 | $20.7K | Buy |
16,964
+16,327
| +2,563% | +$19.9K | ﹤0.01% | 1180 |
|
|
2024
Q1 | $1.39K | Hold |
637
| – | – | ﹤0.01% | 1535 |
|
|
2023
Q4 | $987 | Hold |
637
| – | – | ﹤0.01% | 1675 |
|
|
2023
Q3 | $822 | Sell |
637
-2,998
| -82% | -$3.87K | ﹤0.01% | 1713 |
|
|
2023
Q2 | $6.25K | Buy |
3,635
+2,500
| +220% | +$4.3K | ﹤0.01% | 1373 |
|
|
2023
Q1 | $1.71K | Buy |
1,135
+939
| +479% | +$1.42K | ﹤0.01% | 1563 |
|
|
2022
Q4 | $314 | Hold |
196
| – | – | ﹤0.01% | 1797 |
|
|
2022
Q3 | $0 | Hold |
196
| – | – | ﹤0.01% | 2239 |
|
|
2022
Q2 | $0 | Sell |
196
-300
| -60% | – | ﹤0.01% | 2271 |
|
|
2022
Q1 | $1K | Sell |
496
-1,015
| -67% | -$2.05K | ﹤0.01% | 1942 |
|
|
2021
Q4 | $7K | Buy |
+1,511
| New | +$7K | ﹤0.01% | 1932 |
|
|
2021
Q3 | – | Sell |
-1,800
| Closed | -$11K | – | 2301 |
|
|
2021
Q2 | $11K | Buy |
1,800
+700
| +64% | +$4.28K | ﹤0.01% | 1755 |
|
|
2021
Q1 | $9K | Buy |
+1,100
| New | +$9K | ﹤0.01% | 1639 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1861 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1732 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1580 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 1521 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1499 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 1505 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1540 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 1478 |
|
|
2018
Q1 | – | Sell |
-300
| Closed | -$6K | – | 1434 |
|
|
2017
Q4 | $6K | Buy |
+300
| New | +$6K | ﹤0.01% | 1220 |
|